Genpharmasec Limited (BOM:531592)
India flag India · Delayed Price · Currency is INR
1.080
0.00 (0.00%)
At close: Nov 17, 2026

Genpharmasec Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Revenue
2,3061,399337.22304.06255.16273.21
2,3061,399337.22304.06255.16273.21
Revenue Growth
243.33%314.98%10.91%19.16%-6.61%28.22%
Cost of Revenue
2,1351,286307.52242.33233.97265.65
Gross Profit
171.26113.5829.761.7321.187.55
Selling, General & Admin
45.6938.8410.399.186.833.59
Other Operating Expenses
90.5461.0513.0252.0911.679.18
Operating Expenses
163.19121.5731.5361.6918.712.91
Operating Income
8.07-7.99-1.830.042.48-5.36
Interest Expense
-15.92-10.99-4.34-4.09-0.56-
Interest & Investment Income
11.3411.3419.5300.310.65
Currency Exchange Gain (Loss)
2.852.850.961.830.550.16
Other Non Operating Income (Expenses)
12.659.92--00.040.11
EBT Excluding Unusual Items
18.995.1214.33-2.222.82-4.43
Gain (Loss) on Sale of Investments
5.115.117.794.73--
Gain (Loss) on Sale of Assets
-0.84-0.84----
Other Unusual Items
0.320.32----
Pretax Income
23.589.7122.122.512.82-4.43
Income Tax Expense
9.814.116.494.2-8.43-2.34
Earnings From Continuing Operations
13.775.615.63-1.6911.25-2.09
Minority Interest in Earnings
11.8510.440.23---
Net Income
25.6116.0415.86-1.6911.25-2.09
Net Income to Common
25.6116.0415.86-1.6911.25-2.09
Net Income Growth
972.57%1.12%----
Shares Outstanding (Basic)
1,144554554307277277
Shares Outstanding (Diluted)
1,144554554307277277
Shares Change
94.07%-80.25%10.96%-2.06%
EPS (Basic)
0.020.030.03-0.010.04-0.01
EPS (Diluted)
0.020.030.03-0.010.04-0.01
EPS Growth
1047.69%1.12%----

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
-182.64-180.73-27.54-29.64-30.76-24.25
Free Cash Flow Per Share
-0.16-0.33-0.05-0.10-0.11-0.09
Gross Margin
7.43%8.12%8.81%20.30%8.30%2.77%
Operating Margin
0.35%-0.57%-0.54%0.01%0.97%-1.96%
Profit Margin
1.11%1.15%4.70%-0.56%4.41%-0.77%
Free Cash Flow Margin
-7.92%-12.91%-8.17%-9.75%-12.05%-8.88%
EBITDA
29.017.591.630.212.68-5.21
EBITDA Margin
1.26%0.54%0.48%0.07%1.05%-1.91%
D&A For EBITDA
20.9415.583.450.170.20.14
EBIT
8.07-7.99-1.830.042.48-5.36
EBIT Margin
0.35%-0.57%-0.54%0.01%0.97%-1.96%
Effective Tax Rate
41.61%42.30%29.34%167.56%--
Revenue as Reported
2,3411,431367.84310.62256.16274.13